These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30412753)

  • 1. The interactive effect of valence and context on reversal learning in individuals with Parkinson's disease.
    Levy-Gigi E; Haim-Nachum S; Hall JM; Crouse JJ; Winwood-Smith R; Lewis SJG; Moustafa AA
    Neurosci Lett; 2019 Jan; 692():216-224. PubMed ID: 30412753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study.
    Argyelan M; Herzallah M; Sako W; DeLucia I; Sarpal D; Vo A; Fitzpatrick T; Moustafa AA; Eidelberg D; Gluck M
    Neuroreport; 2018 May; 29(7):532-540. PubMed ID: 29432300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reward and Punishment Learning as Predictors of Cognitive Behavioral Therapy Response in Parkinson's Disease Comorbid with Clinical Depression.
    Perskaudas R; Myers CE; Interian A; Gluck MA; Herzallah MM; Baum A; Dobkin RD
    J Geriatr Psychiatry Neurol; 2024 Jul; 37(4):282-293. PubMed ID: 38158704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reward learning deficits in Parkinson's disease depend on depression.
    Timmer MHM; Sescousse G; van der Schaaf ME; Esselink RAJ; Cools R
    Psychol Med; 2017 Oct; 47(13):2302-2311. PubMed ID: 28374660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication.
    Swainson R; Rogers RD; Sahakian BJ; Summers BA; Polkey CE; Robbins TW
    Neuropsychologia; 2000; 38(5):596-612. PubMed ID: 10689037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal learning in Parkinson's disease depends on medication status and outcome valence.
    Cools R; Altamirano L; D'Esposito M
    Neuropsychologia; 2006; 44(10):1663-73. PubMed ID: 16730032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levodopa impairs probabilistic reversal learning in healthy young adults.
    Vo A; Seergobin KN; Morrow SA; MacDonald PA
    Psychopharmacology (Berl); 2016 Jul; 233(14):2753-63. PubMed ID: 27241710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine precursor depletion improves punishment prediction during reversal learning in healthy females but not males.
    Robinson OJ; Standing HR; DeVito EE; Cools R; Sahakian BJ
    Psychopharmacology (Berl); 2010 Aug; 211(2):187-95. PubMed ID: 20495788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired learning of punishments in Parkinson's disease with and without impulse control disorder.
    Leplow B; Sepke M; Schönfeld R; Pohl J; Oelsner H; Latzko L; Ebersbach G
    J Neural Transm (Vienna); 2017 Feb; 124(2):217-225. PubMed ID: 27848033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The temporal dynamics of reversal learning: P3 amplitude predicts valence-specific behavioral adjustment.
    Donaldson KR; Ait Oumeziane B; Hélie S; Foti D
    Physiol Behav; 2016 Jul; 161():24-32. PubMed ID: 27059320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired context reversal learning, but not cue reversal learning, in patients with amnestic mild cognitive impairment.
    Levy-Gigi E; Kelemen O; Gluck MA; Kéri S
    Neuropsychologia; 2011 Oct; 49(12):3320-6. PubMed ID: 21856321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probabilistic reversal learning is impaired in Parkinson's disease.
    Peterson DA; Elliott C; Song DD; Makeig S; Sejnowski TJ; Poizner H
    Neuroscience; 2009 Nov; 163(4):1092-101. PubMed ID: 19628022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Parkinson's disease and dopaminergic medication on adaptation to explicit and implicit visuomotor perturbations.
    Mongeon D; Blanchet P; Messier J
    Brain Cogn; 2013 Mar; 81(2):271-82. PubMed ID: 23313834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor procedural learning in Parkinson's disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Brain; 2007 Nov; 130(Pt 11):2887-97. PubMed ID: 17855374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-Dependent Loss Aversion during Effort-Based Decision-Making.
    Chen X; Voets S; Jenkinson N; Galea JM
    J Neurosci; 2020 Jan; 40(3):661-670. PubMed ID: 31727795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
    MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
    Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Selective Role for Dopamine in Learning to Maximize Reward But Not to Minimize Effort: Evidence from Patients with Parkinson's Disease.
    Skvortsova V; Degos B; Welter ML; Vidailhet M; Pessiglione M
    J Neurosci; 2017 Jun; 37(25):6087-6097. PubMed ID: 28539420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine Selectively Modulates the Outcome of Learning Unnatural Action-Valence Associations.
    Van Wouwe NC; Claassen DO; Neimat JS; Kanoff KE; Wylie SA
    J Cogn Neurosci; 2017 May; 29(5):816-826. PubMed ID: 28129053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motivation, reward, and Parkinson's disease: influence of dopatherapy.
    Czernecki V; Pillon B; Houeto JL; Pochon JB; Levy R; Dubois B
    Neuropsychologia; 2002; 40(13):2257-67. PubMed ID: 12417456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors underlying probabilistic and deterministic stimulus-response learning performance in medicated and unmedicated patients with Parkinson's disease.
    Moustafa AA; Krishna R; Eissa AM; Hewedi DH
    Neuropsychology; 2013 Jul; 27(4):498-510. PubMed ID: 23876122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.